Tilray is full steam ahead in taking on some established players in the food and drug industry. CEO Brendan Kennedy discusses the company's efforts to grow.
Medicinal cannabis company Tilray saw a robust response to its IPO on the Nasdaq Thursday. TheStreet talks with Tilray's CEO Brendan Kennedy about the company's prospects.
After interviewing National Economic Council Director Larry Kudlow, TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer said it's going to be hard to be in a trade war with China, which has a president for life.